Literature DB >> 9510861

Inhibition of DNA methylation in malignant MOLT F4 lymphoblasts by 6-mercaptopurine.

L H Lambooy1, P A Leegwater, L P van den Heuvel, J P Bökkerink, R A De Abreu.   

Abstract

Treatment of MOLT F4 lymphoblasts with 6-mercaptopurine (6-MP) resulted in a decrease of ATP and a depletion of S-adenosylmethionine (AdoMet). To investigate whether this might affect the methylation of DNA, we treated MOLT F4 lymphoblasts with increasing concentrations of 6-MP, followed by labeling with [methyl-14C]methionine and [methyl-3H]thymidine. After DNA isolation, we measured the incorporated radioactivity and determined the 14C/3H ratio as a measure for the methylation of newly formed DNA. The 14C/3H ratio was decreased by 17% with 1 mumol/L 6-MP; treatment with increasing concentrations of 6-MP up to 10 mumol/L showed a further decrease to 70%, in comparison with untreated cells. To demonstrate that the methylation of deoxycytidine residues in DNA was reduced, we quantified hydrolyzed DNA by HPLC. The 14C/3H ratio showed a decrease with increasing 6-MP concentrations, indicating that treatment with 6-MP resulted in hypomethylation of DNA.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9510861

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1.

Authors:  Bifeng Yuan; Jing Zhang; Hongxia Wang; Lei Xiong; Qian Cai; Tina Wang; Steven Jacobsen; Sriharsa Pradhan; Yinsheng Wang
Journal:  Cancer Res       Date:  2011-01-14       Impact factor: 12.701

2.  6-Thioguanine perturbs cytosine methylation at the CpG dinucleotide site by DNA methyltransferases in vitro and acts as a DNA demethylating agent in vivo.

Authors:  Hongxia Wang; Yinsheng Wang
Journal:  Biochemistry       Date:  2009-03-17       Impact factor: 3.162

Review 3.  Pharmacogenetics of thiopurines.

Authors:  Raffaella Franca; Giulia Zudeh; Sofia Pagarin; Marco Rabusin; Marianna Lucafò; Gabriele Stocco; Giuliana Decorti
Journal:  Cancer Drug Resist       Date:  2019-06-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.